Quick Takeaways: Why It Matters? IDEXX’s Catalyst proBNP brings a well‑known heart‑disease blood test into the vet clinic with results in minutes, so vets can spot hidden heart problems, decide quickly in breathing emergencies, and monitor patients without waiting day...
Quick Takeaways: Why It Matters? Royal Canin’s Fresh Veterinary Diets give veterinarians a fresh, fully cooked therapeutic option in a fast-growing US therapeutic dog food market, aligning medical nutrition with owner demand for “fresh” feeding and strengthening Royal Canin’s position agai...
Quick Takeaways: Why It Matters? Sumitomo’s follow-on investment in A’alda Japan Group is a strategic bet on consolidating and digitizing Japan’s veterinary care, using A’alda’s Vet360 EMR and Vets Ask AI alongside Sumitomo’s DX capabilities to build a vertically integrated, technology-ena...
Quick Takeaways: Why It Matters? By combining Small Door’s recurring membership primary-care model with Bond Vet’s urgent, dental, and surgical capabilities, the new network can increase lifetime value per pet, smooth demand across routine and unscheduled visits, and cross-sell services an...
Quick Takeaways: Why It Matters? Dechra’s Boston HQ move and community-facing strategy signal how veterinary pharma is increasingly aligning with mainstream human health and life sciences ecosystems, not just traditional animal-health hubs, which could intensify competition for talent, par...
Quick Takeaways: Why It Matters? Chewy is using the Modern Animal acquisition to bolt a fast-growing, tech-enabled clinic network onto its retail, pharmacy, and insurance stack, expanding Chewy Vet Care from 18 to 47 locations and adding over 125 million dollars in hi...
Quick Takeaways: Why It Matters? The EUAs immediately expand the therapeutic toolkit for a serious, fast-moving parasitic threat, positioning NexGard and NexGard COMBO as go‑to options if New World screwworm spreads beyond current foci in northern Mexico.&nb...
Quick Takeaways Why It Matters? The merger creates one of the most integrated players in animal health, combining physical distribution, practice software, and pharmacy services into a single, tech-enabled platform that can embed itself deeply in veterinary workflows. Vet...
Quick Takeaways: Why It Matters? MUMS status gives Masivet a clearer US regulatory and commercial path, adding potential 7‑year market exclusivity and grant support on top of its established European use, which should enhance the asset’s value as AB Science courts par...
Quick Takeaways: Why It Matters? The recall may temporarily weaken confidence in Neogen’s veterinary portfolio and open space for rival hyaluronate or wound-care products. It also underscores regulatory and safety scrutiny around off-label use, likely prompting v...
